INVO Bioscience, Inc. (NASDAQ:INVO) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET

Company Participants

Robert Blum - Lytham Partners, IR

Steven Shum - Chief Executive Officer

Mike Campbell - Chief Operating Officer and VP, Business Development

Andrea Goren - Chief Financial Officer

Conference Call Participants

John Heerdink - Vista Partners LLC

Operator

Good day. And welcome to the INVO Bioscience Reports on the Third Quarter 2022 Financial Results Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. Please note, this event is being recorded.

I would now like to turn the conference over to Robert Blum with Lytham Partners. Please go ahead.

Robert Blum

All right. Thank you very much, Jason. Good afternoon, everyone. And thank you for joining us for today’s INVO Bioscience third quarter 2022 financial results conference call. Joining us on today’s call is INVO Bioscience’s CEO, Steven Shum; the company’s Chief Operating Officer and VP of Business Development, Mike Campbell; and Andrea Goren, the company’s Chief Financial Officer. At the conclusion of today’s prepared remarks, we will open the call for a question-and-answer session.

Before we begin with the event, we submit for the record the following statement. Certain matters discussed on this conference call by the management of INVO Bioscience may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, Section 21E of the Securities Exchange Act of 1934 as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

All statements regarding the company’s expected future financial position, results of operations, cash flows, financing plans, business strategies, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as anticipate, if, believe, plan, estimate, expect, intend, may, could, should, will and other similar expressions are forward-looking statements.

All forward-looking statements involve risks and uncertainties and contingencies, many of which are beyond the company’s control, which may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements.

Factors that may cause actual results to do -- to differ materially from those in the forward-looking statements include those set forth in the company’s filings at www.sec.gov. The company is under no obligation to and expressly disclaims any such obligation to update or alter our forward-looking statements, whether results of new information, future events or otherwise.